Last reviewed · How we verify

NCT04406597

Safety, Effectiveness and Operability of Using the New Tissue Containment System During Laparoscopic Ovarian Cystectomy

Status unknown NA Last updated 26 October 2022
What this trial tests

NA trial testing the New Tissue Containment System in Ovary Neoplasm in 400 participants. Status unknown.

Timeline
20 May 2022
Primary endpoint
10 June 2023
10 December 2024

Quick facts

Lead sponsorChina-Japan Friendship Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment400
Start date20 May 2022
Primary completion10 June 2023
Estimated completion10 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China-Japan Friendship Hospital

Who can join

Adults 18 to 45, female only, with Ovary Neoplasm or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to evaluate the safety, effectiveness and operability of performing in-bag cystectomy and morcellation with the new tissue containment system during laparoscopic ovarian cystectomy. Premenopausal women, aged 18-45 undergoing laparoscopic cystectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other China-Japan Friendship Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04406597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing